scholarly journals Measurement nonequivalence of the Clinician-Administered PTSD Scale by race/ethnicity: Implications for quantifying posttraumatic stress disorder severity.

2020 ◽  
Vol 32 (11) ◽  
pp. 1015-1027
Author(s):  
Lesia M. Ruglass ◽  
Antonio A. Morgan-López ◽  
Lissette M. Saavedra ◽  
Denise A. Hien ◽  
Skye Fitzpatrick ◽  
...  
Author(s):  
J. E. Hovens ◽  
H. M. van der Ploeg ◽  
M. T. A. Klaarenbeek ◽  
I. Bramsen ◽  
J. N. Schreuder ◽  
...  

Assessment ◽  
1996 ◽  
Vol 3 (4) ◽  
pp. 437-442 ◽  
Author(s):  
Debra S. Herman ◽  
Frank W. Weathers ◽  
Brett T. Litz ◽  
Terence M. Keane

This study investigated the comparability of the embedded and stand-alone versions of the Keane Posttraumatic Stress Disorder scale ( PK scale) of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2). Participants were 123 Vietnam theater veterans, 68 of whom (55%) were diagnosed with war zone-related posttraumatic stress disorder (PTSD). In separate testing sessions scheduled two to three days apart, all participants first completed the full MMPI-2 followed by the 46 PK scale items administered in a stand-alone format. Sixty participants completed the stand-alone version again in a third session. In addition, all participants were administered the Structured Clinical Interview for DSM-III-R (SCID), including the PTSD module, and completed a number of other questionnaire measures of combat exposure and PTSD. Results indicated that the embedded and stand-alone versions of the MMPI-2 PK scale are quite comparable in terms of mean scores, internal consistency, convergent validity, and diagnostic utility. Use of the standalone version is indicated for assessment applications in which the full MMPI-2 cannot be administered.


2005 ◽  
Vol 97 (1) ◽  
pp. 297-308 ◽  
Author(s):  
Anke B. Witteveen ◽  
Inge Bramsen ◽  
Johannes E. Hovens ◽  
Henk M. van der Ploeg

This study assesses the optimal cut-off point for the Impact of Event Scale and compares its screening properties with those of the Self-rating Inventory for Posttraumatic Stress Disorder among war-related trauma victims. 74 patients with war-related trauma were administered the Impact of Event Scale and the Self-rating Inventory for Posttraumatic Stress Disorder, followed 1 wk. later by the Clinician-administered PTSD Scale. Receiver operating characteristic analysis indicated for the Impact of Event Scale a sensitivity of .77 and a specificity of .51 at a cut-off value of 36. For the Self-rating Inventory for Posttraumatic Stress Disorder a sensitivity of .86 and a specificity of .69 were found at a cut-off value of 52. The authors conclude that careful use of the Impact of Event Scale as a screening measure for Posttraumatic Stress Disorder is warranted.


2013 ◽  
Vol 7 (5) ◽  
pp. 374-381 ◽  
Author(s):  
G. M. Monawar Hosain ◽  
David M. Latini ◽  
Michael R. Kauth ◽  
Heather Honoré Goltz ◽  
Drew A. Helmer

This study examined the racial/ethnic differences in prevalence and risk factors of sexual dysfunction among postdeployed Iraqi/Afghanistan veterans. A total of 3,962 recently deployed veterans were recruited from Houston Veterans Affairs medical center. The authors examined sociodemographic, medical, mental-health, and lifestyle-related variables. Sexual dysfunction was diagnosed by ICD9-CM code and/or medicines prescribed for sexual dysfunction. Analyses included chi-square, analysis of variance, and multivariate logistic regression. Sexual dysfunction was observed 4.7% in Whites, 7.9% in African Americans, and 6.3% in Hispanics. Age, marital status, smoking, and hypertension were risk factors for Whites, whereas age, marital status, posttraumatic stress disorder and hypertension were significant for African Americans. For Hispanics, only age and posttraumatic stress disorder were significant. This study identified that risk factors of sexual dysfunction varied by race/ethnicity. All postdeployed veterans should be screened; and psychosocial support and educational materials should address race/ethnicity-specific risk factors.


2018 ◽  
Vol 32 (12) ◽  
pp. 1295-1307 ◽  
Author(s):  
Marcela Ot’alora G ◽  
Jim Grigsby ◽  
Bruce Poulter ◽  
Joseph W Van Derveer ◽  
Sara Gael Giron ◽  
...  

Background: Posttraumatic stress disorder often does not resolve after conventional psychotherapies or pharmacotherapies. Pilot studies have reported that 3,4-methylenedioxymethamphetamine (MDMA) combined with psychotherapy reduces posttraumatic stress disorder symptoms. Aims: This pilot dose response trial assessed efficacy and safety of MDMA-assisted psychotherapy across multiple therapy teams. Methods: Twenty-eight people with chronic posttraumatic stress disorder were randomized in a double-blind dose response comparison of two active doses (100 and 125 mg) with a low dose (40 mg) of MDMA administered during eight-hour psychotherapy sessions. Change in the Clinician-Administered PTSD Scale total scores one month after two sessions of MDMA served as the primary outcome. Active dose groups had one additional open-label session; the low dose group crossed over for three open-label active dose sessions. A 12-month follow-up assessment occurred after the final MDMA session. Results: In the intent-to-treat set, the active groups had the largest reduction in Clinician-Administered PTSD Scale total scores at the primary endpoint, with mean (standard deviation) changes of −26.3 (29.5) for 125 mg, −24.4 (24.2) for 100 mg, and −11.5 (21.2) for 40 mg, though statistical significance was reached only in the per protocol set ( p=0.03). Posttraumatic stress disorder symptoms remained lower than baseline at 12-month follow-up ( p<0.001) with 76% ( n=25) not meeting posttraumatic stress disorder criteria. There were no drug-related serious adverse events, and the treatment was well-tolerated. Conclusions: Our findings support previous investigations of MDMA-assisted psychotherapy as an innovative, efficacious treatment for posttraumatic stress disorder.


Sign in / Sign up

Export Citation Format

Share Document